$0.00
(0.00%
) Quote detailsUSD
$0.00
(0.00%
)At Close (As of Nov 26, 2025)
$702.87M
Market Cap
-
P/E Ratio
-2.5
EPS
$10.38
52 Week High
$1.45
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Lexeo Therapeutics, Inc. is a New York-based clinical-stage genetic medicine company dedicated to developing pioneering therapies for hereditary and acquired diseases. Leveraging advanced gene-editing technologies, Lexeo is advancing a robust and diverse pipeline of innovative treatments aimed at addressing significant unmet medical needs and enhancing patient outcomes. With a strong commitment to proprietary platform development, Lexeo is well-positioned to make a substantial impact in the burgeoning field of genetic medicine, representing a compelling opportunity for institutional investors interested in transformative healthcare solutions.
LPTX
NVDA
VHAI
BYND
KTTA
ZYXI
AMBR
BITF
PLUG
NIO
IPG
ASST
CLSK
AAL
TSLA
CIFR
SOFI
INTC
GOOGL
ADAP
MARA
WULF
HOOD
KVUE
F
AMD
SNDK
WBD
DNN
TLRY
BTBT
GRAB
RIG
PLTR
PFE
HBAN
IVP
AGNC
BAC
CCL
SNAP
GOOG
RGTI
AVGO
VALE
NFLX
MTSR
PLTD
T
IREN
ORCL
NTNX
MSFT
ITUB
DVLT
PCG
NOK
CMG
HBI
CAN
HPQ
APLD
LPTX
NVDA
VHAI
BYND
KTTA
ZYXI
AMBR
BITF
PLUG
NIO
IPG
ASST
CLSK
AAL
TSLA
CIFR
SOFI
INTC
GOOGL
ADAP
MARA
WULF
HOOD
KVUE
F
AMD
SNDK
WBD
DNN
TLRY
BTBT
GRAB
RIG
PLTR
PFE
HBAN
IVP
AGNC
BAC
CCL
SNAP
GOOG
RGTI
AVGO
VALE
NFLX
MTSR
PLTD
T
IREN
ORCL
NTNX
MSFT
ITUB
DVLT
PCG
NOK
CMG
HBI
CAN
HPQ
APLD